Who owns ASCENTAGE PHARMA GROUP INTL?
- Ticker: AAPG
- CUSIP Number: 04390b105
Tip: Access positions for across all investors
Analyze quarterly positions in Ascentage Pharma Group Intl with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Ascentage Pharma Group Intl stock
Who bought or sold ASCENTAGE PHARMA GROUP INTL this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Point72 Asset Management | 14k | $243k | -14% | Jun 2026 |
|
| Wells Fargo & Company | 200.00 | $3.5k | 100% | Jun 2026 |
|
| Nuveen | 79.00 | $1.2k | 100% | Sep 2026 |
|
| EverSource Wealth Advisors | 24.00 | $391.000800 | 0% | Sep 2026 |
|
| UBS Group | 15.00 | $262.999500 | -88% | Jun 2026 |
|
| BlackRock | 6.00 | $105.000000 | 100% | Jun 2026 |
|
| Royal Bank of Canada | 6.00 | $0 | 0% | Jun 2026 |
|
| NISA Investment Advisors | 5.00 | $83.000000 | 100% | Sep 2026 |
|
| Citigroup | 1.00 | $17.000000 | 100% | Sep 2026 |
|
| Caitong International Asset Management | 1.00 | $16.000000 | 0% | Sep 2026 |
|
Who sold out of Ascentage Pharma Group Intl?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XY Capital | Mar 2026 | 13k | $311k |
| Tower Research Capital | Mar 2026 | 518.00 | $12k |